Literature DB >> 16862519

Diagnosing von Willebrand disease: a large reference laboratory's perspective.

Dorothy M Adcock1, Melissa Bethel, Andre Valcour.   

Abstract

Von Willebrand disease (vWD) is a common bleeding disorder. Diagnosis requires the demonstration of both clinical and laboratory features consistent with this disorder. Laboratory evaluation is complex, due in part to the variety of assays available and differing opinions regarding the optimum testing methodologies and algorithms required. This study represents a retrospective analysis of cases (n = 497) evaluated in our laboratory in which results for von Willebrand factor (vWF) multimeric analysis, vWF antigen, ristocetin cofactor activity, and collagen-binding activity were available. Results were compared to determine which assay parameters best correlate with one another, alone or in combination, and best correlate with the pattern and distribution of multimers. We demonstrate that performance of vWF activity or antigen assays in isolation can lead to both the overdiagnosis and underdiagnosis of vWD. Incorporation of the collagen-binding assay into the diagnostic algorithm leads to a reduced potential for misdiagnosis or misclassification of vWD and can reduce the number of multimeric analyses required dramatically.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16862519     DOI: 10.1055/s-2006-947860

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  7 in total

Review 1.  Von Willebrand disease in the United States: a perspective from Wisconsin.

Authors:  Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Daniel B Bellissimo; Sandra L Haberichter; Robert R Montgomery
Journal:  Semin Thromb Hemost       Date:  2011-11-18       Impact factor: 4.180

Review 2.  Perils, problems, and progress in laboratory diagnosis of von Willebrand disease.

Authors:  Veronica H Flood
Journal:  Semin Thromb Hemost       Date:  2013-12-12       Impact factor: 4.180

3.  The influence of riboflavin photochemistry on plasma coagulation factors.

Authors:  Luis Larrea; María Calabuig; Vanesa Roldán; José Rivera; Han-Mou Tsai; Vicente Vicente; Roberto Roig
Journal:  Transfus Apher Sci       Date:  2009-09-25       Impact factor: 1.764

4.  Collagen binding provides a sensitive screen for variant von Willebrand disease.

Authors:  Veronica H Flood; Joan Cox Gill; Kenneth D Friedman; Pamela A Christopherson; Paula M Jacobi; Raymond G Hoffmann; Robert R Montgomery; Sandra L Haberichter
Journal:  Clin Chem       Date:  2013-01-22       Impact factor: 8.327

5.  ASH ISTH NHF WFH 2021 guidelines on the diagnosis of von Willebrand disease.

Authors:  Paula D James; Nathan T Connell; Barbara Ameer; Jorge Di Paola; Jeroen Eikenboom; Nicolas Giraud; Sandra Haberichter; Vicki Jacobs-Pratt; Barbara Konkle; Claire McLintock; Simon McRae; Robert R Montgomery; James S O'Donnell; Nikole Scappe; Robert Sidonio; Veronica H Flood; Nedaa Husainat; Mohamad A Kalot; Reem A Mustafa
Journal:  Blood Adv       Date:  2021-01-12

6.  von Willebrand factor levels in the diagnosis of von Willebrand disease: a systematic review and meta-analysis.

Authors:  Mohamad A Kalot; Nedaa Husainat; Abdallah El Alayli; Omar Abughanimeh; Osama Diab; Sammy Tayiem; Bader Madoukh; Ahmad B Dimassi; Aref Qureini; Barbara Ameer; Jeroen C J Eikenboom; Nicolas Giraud; Claire McLintock; Simon McRae; Robert R Montgomery; James S O'Donnell; Nikole Scappe; Robert F Sidonio; Romina Brignardello-Petersen; Veronica H Flood; Nathan T Connell; Paula D James; Reem A Mustafa
Journal:  Blood Adv       Date:  2022-01-11

7.  Establishment and characterization of a new and stable collagen-binding assay for the assessment of von Willebrand factor activity.

Authors:  Y Ni; J Nesrallah; M Agnew; F J Geske; E J Favaloro
Journal:  Int J Lab Hematol       Date:  2012-10-29       Impact factor: 2.877

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.